AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,468,000 | -76.2% | 42,600 | -88.5% | 0.00% | -75.0% |
| Q2 2020 | $6,180,000 | +17.7% | 369,843 | +1.6% | 0.01% | 0.0% |
| Q1 2020 | $5,251,000 | -59.6% | 364,143 | -6.2% | 0.01% | -46.7% |
| Q4 2019 | $12,988,000 | +127.2% | 388,038 | +42.2% | 0.02% | +114.3% |
| Q3 2019 | $5,716,000 | +476.8% | 272,972 | +473.5% | 0.01% | +600.0% |
| Q2 2019 | $991,000 | +4.3% | 47,600 | +12.0% | 0.00% | 0.0% |
| Q1 2019 | $950,000 | -6.6% | 42,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,017,000 | -22.7% | 42,500 | -11.8% | 0.00% | -50.0% |
| Q3 2018 | $1,315,000 | +1.5% | 48,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,296,000 | +4.1% | 48,200 | +23.3% | 0.00% | 0.0% |
| Q1 2018 | $1,245,000 | -63.8% | 39,100 | -57.0% | 0.00% | -50.0% |
| Q4 2017 | $3,442,000 | +269.3% | 91,023 | +142.1% | 0.00% | +300.0% |
| Q3 2017 | $932,000 | +20.6% | 37,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $773,000 | +32.1% | 37,600 | +39.8% | 0.00% | 0.0% |
| Q1 2017 | $585,000 | +6.4% | 26,901 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $550,000 | +36.1% | 26,900 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $404,000 | +38.8% | 26,900 | 0.0% | 0.00% | – |
| Q2 2016 | $291,000 | +100.7% | 26,900 | +151.4% | 0.00% | – |
| Q1 2016 | $145,000 | -26.4% | 10,700 | 0.0% | 0.00% | – |
| Q4 2015 | $197,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |